ATyr Pharma Price on May 7, 2024
If you're considering investing in ATyr Stock, it is important to understand the factors that can impact its price. We have found twenty-one technical indicators for ATyr Pharma, which you can use to evaluate the volatility of the firm. Please confirm ATyr Pharma's Risk Adjusted Performance of 0.0882, downside deviation of 3.02, and Mean Deviation of 2.57 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
ATyr Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
ATyr |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
LIFE |
Based on monthly moving average ATyr Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ATyr Pharma by adding ATyr Pharma to a well-diversified portfolio.
ATyr Pharma Valuation on May 7, 2024
It is possible to determine the worth of ATyr Pharma on a given historical date. On May 7, 2024 ATyr was worth 1.69 at the beginning of the trading date compared to the closed value of 1.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ATyr Pharma stock. Still, in general, we apply an absolute valuation method to find ATyr Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ATyr Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ATyr Pharma's related companies.
Open | High | Low | Close | Volume | |
1.65 | 1.75 | 1.59 | 1.66 | 1,323,698 | |
05/07/2024 | 1.69 | 1.71 | 1.64 | 1.70 | 256,475 |
1.68 | 1.72 | 1.63 | 1.69 | 271,164 |
Backtest ATyr Pharma | | | ATyr Pharma History | | | ATyr Pharma Valuation | Previous | Next |
ATyr Pharma Trading Date Momentum on May 7, 2024
On May 08 2024 ATyr Pharma was traded for 1.69 at the closing time. The top price for the day was 1.72 and the lowest listed price was 1.63 . The trading volume for the day was 271.2 K. The trading history from May 8, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.59% . The overall trading delta against the current closing price is 12.94% . |
ATyr Pharma Fundamentals Correlations and Trends
By evaluating ATyr Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ATyr Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ATyr financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ATyr Pharma Stock history
ATyr Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ATyr is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ATyr Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ATyr Pharma stock prices may prove useful in developing a viable investing in ATyr Pharma
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company was incorporated in 2005 and is headquartered in San Diego, California. Atyr Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 49 people.
ATyr Pharma Stock Technical Analysis
ATyr Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
ATyr Pharma Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
ATyr Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ATyr Pharma December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how ATyr Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ATyr Pharma shares will generate the highest return on investment. By undertsting and applying ATyr Pharma stock market strength indicators, traders can identify ATyr Pharma entry and exit signals to maximize returns
ATyr Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ATyr Pharma's price direction in advance. Along with the technical and fundamental analysis of ATyr Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ATyr to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0882 | |||
Jensen Alpha | 0.3888 | |||
Total Risk Alpha | 0.178 | |||
Sortino Ratio | 0.1177 | |||
Treynor Ratio | 1.75 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in ATyr Stock
If you are still planning to invest in ATyr Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ATyr Pharma's history and understand the potential risks before investing.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |